Terms: = Thyroid cancer AND Ki-67 AND Prognosis
107 results:
1. Characteristics and immune checkpoint status of radioiodine-refractory recurrent papillary thyroid carcinomas from Ukrainian Chornobyl Tissue Bank donors.
Bogdanova T; Rogounovitch TI; Zurnadzhy L; Mitsutake N; Tronko M; Ito M; Bolgov M; Chernyshov S; Gulevatyi S; Masiuk S; Yamashita S; Saenko VA
Front Endocrinol (Lausanne); 2023; 14():1343848. PubMed ID: 38260161
[TBL] [Abstract] [Full Text] [Related]
2. Clinical characteristics and prognosis of postpartum breast cancer.
Paik PS; Choi JE; Lee SW; Lee YJ; Kang YJ; Lee HJ; Bae SY;
Breast Cancer Res Treat; 2023 Nov; 202(2):275-286. PubMed ID: 37542632
[TBL] [Abstract] [Full Text] [Related]
3. [Clinicopathological features of thyroid-like low-grade nasopharyngeal papillary adenocarcinoma].
Zhu M; Li J; Zheng WH; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2023 Aug; 52(8):820-826. PubMed ID: 37527987
[No Abstract] [Full Text] [Related]
4. Correlation of PKM2 Expression With HER2/neu and Additional Breast cancer Biomarkers and its Prognostic Significance.
Al-Qudah MA; Al-Keilani MS; Obeidat M; Haddad HK; Bdeir R; Samman LM
Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):363-370. PubMed ID: 37212690
[TBL] [Abstract] [Full Text] [Related]
5. Organoid models derived from patients with malignant phyllodes tumor of the breast.
Chu X; Wu M; Yang J; Fu Y; Wang X; Wang H; Xiao Y; Chen D; He J
Breast Cancer Res Treat; 2023 Jul; 200(2):193-201. PubMed ID: 37204665
[TBL] [Abstract] [Full Text] [Related]
6. Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer.
Liang X; Gao X; Wang F; Li S; Zhou Y; Guo P; Meng Y; Lu T
Cancer Med; 2023 Jul; 12(13):14171-14182. PubMed ID: 37184108
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA-130a-3p impedes the progression of papillary thyroid carcinoma through downregulation of KPNB1 by targeting PSME3.
Wang Y; Xu J; Zhu X; Kuang H
Endocrine; 2023 Oct; 82(1):96-107. PubMed ID: 37166548
[TBL] [Abstract] [Full Text] [Related]
8. Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.
Murakami M; Fujimori N; Nakata K; Nakamura M; Hashimoto S; Kurahara H; Nishihara K; Abe T; Hashigo S; Kugiyama N; Ozawa E; Okamoto K; Ishida Y; Okano K; Takaki R; Shimamatsu Y; Ito T; Miki M; Oza N; Yamaguchi D; Yamamoto H; Takedomi H; Kawabe K; Akashi T; Miyahara K; Ohuchida J; Ogura Y; Nakashima Y; Ueki T; Ishigami K; Umakoshi H; Ueda K; Oono T; Ogawa Y
J Gastroenterol; 2023 Jun; 58(6):586-597. PubMed ID: 37099152
[TBL] [Abstract] [Full Text] [Related]
9. Papillary thyroid carcinoma with aggressive fused follicular and solid growth pattern: A unique histological subtype with high-grade malignancy?
Murata SI; Matsuzaki I; Kishimoto M; Katsuki N; Onishi T; Hirokawa M; Kojima F
Pathol Int; 2023 May; 73(5):207-211. PubMed ID: 37042564
[TBL] [Abstract] [Full Text] [Related]
10. Expression and Clinical Significance of Golgi Phosphoprotein 3 (GOLPH3) in Papillary thyroid Carcinoma.
Yu WS; Zhou ZP; Zeng JF; Huang ZQ; Qiu CZ
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):324-330. PubMed ID: 36952588
[TBL] [Abstract] [Full Text] [Related]
11. Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre-operative identification of high-risk cases.
Hysek M; Hellgren LS; Stenman A; Darai-Ramqvist E; Ljung E; Schliemann I; Condello V; Larsson C; Zedenius J; Jatta K; Juhlin CC
Diagn Cytopathol; 2023 Jun; 51(6):331-340. PubMed ID: 36870048
[TBL] [Abstract] [Full Text] [Related]
12. The Value of ki-67 Labeling Index in Central Lymph Node Metastasis and Survival of Papillary thyroid Carcinoma: Evidence From the Clinical and Molecular Analyses.
Lei Y; Zhao X; Feng Y; He D; Hu D; Min Y
Cancer Control; 2023; 30():10732748231155701. PubMed ID: 36744396
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of factors predicting postoperative recurrence and metastasis of parathyroid cancer: a single-center study.
Ohkuwa K; Katoh R; Sugino K; Nagahama M; Kitagawa W; Matsuzu K; Fukunari N; Ito K
World J Surg Oncol; 2023 Feb; 21(1):32. PubMed ID: 36737774
[TBL] [Abstract] [Full Text] [Related]
14. LMCD1-AS1 Facilitates Cell Proliferation and EMT by Sponging miR-873-3p in Cervical cancer.
Liang M; Li Y; Chen C
Crit Rev Eukaryot Gene Expr; 2023; 33(2):13-25. PubMed ID: 36734854
[TBL] [Abstract] [Full Text] [Related]
15. [Effects of adjuvant trastuzumab on long-term survival of T1N0M0 stage human epidermal growth factor receptor 2 positive breast cancer: a real-world study].
Sun TH; Lu ZN; Song HT; Sun G
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):101-107. PubMed ID: 36709127
[No Abstract] [Full Text] [Related]
16. Thyroglobulin expression, ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer.
Lindfors H; Karlsen M; Karlton E; Zedenius J; Larsson C; Ihre Lundgren C; Juhlin CC; Shabo I
Sci Rep; 2023 Jan; 13(1):1070. PubMed ID: 36658256
[TBL] [Abstract] [Full Text] [Related]
17. Survival of women with pregnancy-associated breast cancer according to clinical characteristics: A propensity score matching study.
Gwak H; Woo SS; Lee ES; Park MH; Lee S; Youn HJ; Park S; Suh IS; Kim SH
Medicine (Baltimore); 2022 Oct; 101(40):e30831. PubMed ID: 36221366
[TBL] [Abstract] [Full Text] [Related]
18. Overexpression of PBK/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis.
Qiao L; Ba J; Xie J; Zhu R; Wan Y; Zhang M; Jin Z; Guo Z; Yu J; Chen S; Yao Y
World J Surg Oncol; 2022 Sep; 20(1):316. PubMed ID: 36171591
[TBL] [Abstract] [Full Text] [Related]
19. Identification of HMGB2 associated with proliferation, invasion and prognosis in lung adenocarcinoma via weighted gene co-expression network analysis.
Qiu X; Liu W; Zheng Y; Zeng K; Wang H; Sun H; Dai J
BMC Pulm Med; 2022 Aug; 22(1):310. PubMed ID: 35962344
[TBL] [Abstract] [Full Text] [Related]
20. The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score.
Yang ZJ; Liu YX; Huang Y; Chen ZJ; Zhang HZ; Yu Y; Wang X; Cao XC
Cancer Med; 2023 Feb; 12(3):2493-2504. PubMed ID: 35909232
[TBL] [Abstract] [Full Text] [Related]
[Next]
